WebMar 25, 2024 · Regor’s research on such agonists, the suit says, is actually the work of Wenge Zhong, a long-time Amgen medicinal chemist who joined Qilu Regor, Regor’s China … WebMedia Contact: Shanghai, April. 12, 2024 --Regor Therapeutics Group, a clinical-stage biotech company focusing on immunology, oncology, and metabolic disorders, announced today that the first patient has been dosed in the Phase II clinical trial of the Company’s novel oral small molecule GLP-1 receptor agonist RGT-075 in the U.S.
Eric Wesoloski - Executive Direct.. - Regor Therapeutics ZoomInfo
WebFeb 19, 2024 · Founded in July of 2024 by a group of veteran drug hunters with extensive research and executive leadership experiences at top multinational pharmaceutical … WebOct 4, 2024 · By Marjorie E. Zettler, Ph.D., MPH, executive director of clinical science, Regor Pharmaceuticals, Inc. First launched in February 2024 by the FDA’s Oncology Center of Excellence, the Real-Time Oncology Review (RTOR) program is intended to streamline the review process for oncology drug applications. goddess of youth greek
Regor Therapeutics Group
WebRegor Therapeutics. Manufacturing · Massachusetts, United States · <25 Employees . Started in 2024 and based in Boston, Massachusetts, Regor Therapeutics is a biopharmaceutical company that specializes in developing therapeutics in the areas of oncology, metabolic diseases and autoimmune diseases. WebDec 10, 2024 · Regor will receive an upfront payment of up to $50 million, which partially includes an equity investment by Lilly in Regor, subject to the parties entering into … WebHome. About Us. Founded in 2024 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical … bonsai by edith tiempo moral lesson